相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets
Z. M. Younossi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease
Alison J. Dawson et al.
CLINICAL ENDOCRINOLOGY (2014)
Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
H. Kahal et al.
CLINICAL ENDOCRINOLOGY (2014)
OBSTRUCTIVE SLEEP APNEA PREDISPOSES TO NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME
Luciana Tock et al.
ENDOCRINE PRACTICE (2014)
Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis
Giovanni Tarantino et al.
CLINICAL ENDOCRINOLOGY (2013)
Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile
Sara F. Michaliszyn et al.
FERTILITY AND STERILITY (2013)
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp
Nigel K. Stepto et al.
HUMAN REPRODUCTION (2013)
Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
Susana Borruel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
Richard S. Legro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Adverse Effects of the Common Treatments for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Juan Pablo Domecq et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Molecular signature of adipose tissue in patients with both Non-Alcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovarian Syndrome (PCOS)
Ancha Baranova et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Yan-Yan Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome
Carley A. Gomez-Meade et al.
WORLD JOURNAL OF DIABETES (2013)
Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
Y. Yilmaz
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Phenotypes and Enviromental Factors: Their Influence in PCOS
Evanthia Diamanti-Kandarakis et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
G. Musso et al.
DIABETOLOGIA (2012)
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Harpal S. Randeva et al.
ENDOCRINE REVIEWS (2012)
Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
Claudia O. Zein et al.
HEPATOLOGY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Activation of PKR/eIF2a signaling cascade is associated with dihydrotestosterone-induced cell cycle arrest and apoptosis in human liver cells
Rongyang Dai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Polycystic Ovary Syndrome with Hyperandrogenism Is Characterized by an Increased Risk of Hepatic Steatosis Compared to Nonhyperandrogenic PCOS Phenotypes and Healthy Controls, Independent of Obesity and Insulin Resistance
Helen Jones et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese
Judith Aron-Wisnewsky et al.
JOURNAL OF HEPATOLOGY (2012)
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Helen M. Parker et al.
JOURNAL OF HEPATOLOGY (2012)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
Christian Thoma et al.
JOURNAL OF HEPATOLOGY (2012)
Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease?
L. Lind et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis
Ke-Qing Shi et al.
MOLECULAR BIOLOGY REPORTS (2012)
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease
A. Baranova et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome
Maria F. Gangale et al.
CLINICAL ENDOCRINOLOGY (2011)
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
Jennifer Villa et al.
CURRENT DIABETES REPORTS (2011)
The Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic
Brian A. Neel et al.
DIABETES (2011)
Current perspectives of insulin resistance and polycystic ovary syndrome
J. M. Pauli et al.
DIABETIC MEDICINE (2011)
Fatty liver index in polycystic ovary syndrome
Elisabeth Lerchbaum et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study
Gwinnett Ladson et al.
FERTILITY AND STERILITY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Adipose Tissue Has Aberrant Morphology and Function in PCOS: Enlarged Adipocytes and Low Serum Adiponectin, But Not Circulating Sex Steroids, Are Strongly Associated with Insulin Resistance
Louise Manneras-Holm et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Sonographic Measurement of Mesenteric Fat Predicts Presence of Fatty Liver among Subjects with Polycystic Ovary Syndrome
R. C. W. Ma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Prevalence, gender, ethnic variations, and prognosis of NASH
Etsuko Hashimoto et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)
Noreen Hossain et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Lifestyle changes in women with polycystic ovary syndrome
Lisa J. Moran et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
H. Teede et al.
BMC MEDICINE (2010)
Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome
Athina Markouo et al.
FERTILITY AND STERILITY (2010)
Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Do androgens play a role?
Robert P. Kauffman et al.
GYNECOLOGICAL ENDOCRINOLOGY (2010)
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
Wendy A. March et al.
HUMAN REPRODUCTION (2010)
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
E. Vassilatou et al.
HUMAN REPRODUCTION (2010)
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
Lisa J. Moran et al.
HUMAN REPRODUCTION UPDATE (2010)
Apoptotic Markers Indicate Nonalcoholic Steatohepatitis in Polycystic Ovary Syndrome
Susanne Tan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Hyperandrogenemia Is Independently Associated with Elevated Alanine Aminotransferase Activity in Young Women with Polycystic Ovary Syndrome
Mei-Jou Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Apoptosis and Cytokinesin Non-Alcoholic Steatohepatitis
Wing-Kin Syn et al.
CLINICS IN LIVER DISEASE (2009)
The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans
Kayoung Lee et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Serum resistin and adiponectin levels in women with polycystic ovary syndrome
Murat Yilmaz et al.
GYNECOLOGICAL ENDOCRINOLOGY (2009)
Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis: A Multicenter Validation Study
Ariel E. Feldstein et al.
HEPATOLOGY (2009)
In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls
Frangiskos Economou et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2009)
Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
Andrea J. Cussons et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome
Malgorzata M. Brzozowska et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
The Prevalence of Abnormal Liver Enzymes and Metabolic Syndrome in Obese Adolescent Females with Polycystic Ovary Syndrome
Elaine Barfield et al.
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2009)
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Rajasekhara R. Mummadi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
G. Targher et al.
DIABETOLOGIA (2008)
Consensus on infertility treatment related to polycystic ovary syndrome
B. C. Tarlatzis et al.
FERTILITY AND STERILITY (2008)
Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma
Cheng-Lung Ma et al.
GASTROENTEROLOGY (2008)
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
Anna Ludovica Fracanzani et al.
HEPATOLOGY (2008)
The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome
D. Preiss et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Janus P. Ong et al.
JOURNAL OF HEPATOLOGY (2008)
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
Silvia Sookoian et al.
JOURNAL OF HEPATOLOGY (2008)
Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis
Poonam Mishra et al.
LIVER INTERNATIONAL (2008)
Nonalcoholic fatty liver disease as a complication of insulin resistance
Manal F. Abdelmalek et al.
MEDICAL CLINICS OF NORTH AMERICA (2007)
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Cristian Cerda et al.
JOURNAL OF HEPATOLOGY (2007)
Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals
Andreas Mueller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future
Anna Wieckowska et al.
HEPATOLOGY (2007)
The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome
Anne Corbould et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma
Shiou-Hwei Yeh et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Maya Gambarin-Gelwan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
F. Angelico et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
F. Lirussi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
Ricardo Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women
Francisco Alvarez-Blasco et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women
Janani Arun et al.
OBESITY SURGERY (2006)
Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome
TL Setji et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Chronic liver injury during obstructive sleep apnea
F Tanné et al.
HEPATOLOGY (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
The prevalence and features of the polycystic ovary syndrome in an unselected population
R Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Nonalcoholic fatty liver disease - An underrecognized cause of cryptogenic cirrhosis
JM Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome
R Azziz et al.
FERTILITY AND STERILITY (2003)
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati et al.
ANNALS OF INTERNAL MEDICINE (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Detection of elevated caspase activation and early apoptosis in liver diseases
H Bantel et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2001)
分享论文
